Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Olfactory transduction | R-HSA-9751605 | map04740 | protriptyline | 4976 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | protriptyline | 4976 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | protriptyline | 4976 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | protriptyline | 4976 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | protriptyline | 4976 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | protriptyline | 4976 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | protriptyline | 4976 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | protriptyline | 4976 | drug-path |
| Asthma | R-HSA-444620 | map05310 | protriptyline | 4976 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | protriptyline | 4976 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | protriptyline | 4976 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | remoxipride | 54477 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | remoxipride | 54477 | drug-path |
| Gap junction | R-HSA-190861 | map04540 | remoxipride | 54477 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | remoxipride | 54477 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | remoxipride | 54477 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | remoxipride | 54477 | drug-path |
| SNARE interactions in vesicular transport | R-HSA-428625 | map04130 | remoxipride | 54477 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | progesterone | 5994 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | progesterone | 5994 | drug-path |